BS

Beijing Shenzhen Sai Fund

Description

Beijing Shenzhen Sai Fund is an investment fund.

Investor Profile

Beijing Shenzhen Sai Fund has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Beijing Shenzhen Sai Fund frequently co-invest with?

GreatWall Fund
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Industrial Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
CD Capital
Asia, Zhejiang, China, Ningbo
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
E Fund Management Co.,LTD.
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
China Reform Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Beijing Shenzhen Sai Fund?

Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738